Normalization of multiple hemostatic abnormalities in uremic type 1 diabetic patients after kidney-pancreas transplantation

Diabetes

Volumn 53, Issue 9, 2004, Pages 2291-2300

  Fiorina, Paolo ^a   Folli, Franco ^a   D'Angelo, Armando ^a   Finzi, Giovanna ^b   Pellegatta, Fabio ^c   Guzzi, Valeria ^a   Fedeli, Carlo ^a   Della Valle, Patrizia ^a   Usellini, Luciana ^b   Placidi, Claudia ^b   Bifari, Francesco ^a   Belloni, Daniela ^d   Ferrero, Elisabetta ^a   Capella, Carlo ^b   Secchi, Antonio ^a,e  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c Istituto di Farmacologia   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CALCIUM; CYCLOSPORIN; FIBRINOGEN RECEPTOR; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; THYMOCYTE ANTIBODY;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BLOOD CLOTTING; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; CELL STRUCTURE; CONTROLLED STUDY; FEMALE; HEMOSTASIS; HUMAN; HUMAN CELL; HYPERCOAGULABILITY; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PANCREAS TRANSPLANTATION; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE; UREMIA;

ADULT; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BLOOD PLATELETS; CALCIUM; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION; PARTIAL THROMBOPLASTIN TIME; PLATELET MEMBRANE GLYCOPROTEIN IIB; PROTHROMBIN TIME; RECEPTOR, PAR-1; RECEPTORS, THROMBIN; SIGNAL TRANSDUCTION; UREMIA;

EID: 4344651590     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.9.2291     Document Type: Article

References (54)

1. Rauch U, Ziegler D, Piolot R, Schwippert B, Benthake H, Schultheiss HP, Tschoepe D: Platelet activation in diabetic cardiovascular autonomic neuropathy. Diabet Med 16:848-852, 1999
2. Rink TJ, Sage SO: Calcium signaling in human platelets. Annu Rev Physiol 52:431-449, 1990
3. Vicari AM, Taglietu MV, Pellegatta F, Spotti D, Melandri M, Galli L, Ronchi P, Folli F: Deranged platelet calcium homeostasis in diabetic patients with end-stage renal failure: a possible link to increased cardiovascular mortality? Diabetes Care 19:1062-1066, 1996
4. Winocour PD: Platelet abnormalities in diabetes mellitus. Diabetes 41:26-29, 1992
5. Mustard JF, Packham MA: Platelets and diabetes mellitus. N Engl J Med 311:665-667, 1984
6. Matsubara Y, Murata M, Maruyama T, Handa M, Yamagata N, Watanabe G, Saruta T, Ikeda Y: Association between diabetic retinopathy and genetic variations in α2β1 integrin, a platelet receptor for collagen. Blood 95:1560-1564, 2000
7. Dallinger KJ, Jennings PE, Toop MJ, Clyde OH, Barnett AH: Platelet aggregation and coagulation factors in insulin dependent diabetes with and without microangiopathy. Diabet Med 4:44-48, 1987
8. Pape AL, Gutman N, Guitton JD, Legrand Y, Muh JP: Non enzymatic glycosylation increases platelet aggregating potency of collagen from placenta of diabetic human beings. Biochem Biophys Res Commun 111:602-610, 1983
9. Tschoepe D, Driesch E, Schwippert B, Nieuwenhuis HK, Gries FA: Exposure of adhesion molecules on activated platelets in patients with newly diagnosed IDDM is not normalized by near-normoglycemia. Diabetes 44:890-894, 1995
10. Remuzzi G: Bleeding in renal failure. Lancet 1:1205-1208, 1988
11. Diabetes mellitus: a major risk factor for cardiovascular disease: a joint editorial statement. Circulation 100:1132-1133, 1999
12. Nathan DM: Long-term complications of diabetes mellitus. N Engl J Med 328:1676-1685, 1993
13. Joint Working Party on Diabetic Renal Failure: Renal failure in the UK: deficient provision of care in 1985. Diabet Med 5:79-84, 1988
14. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-126, 1999
15. Aso Y, Inukai T, Takemura Y: Mechanisms of elevation of serum and urinary concentrations of soluble thrombomodulin in diabetic patients: possible application as a marker for vascular endothelial Injury. Metabolism 47:362-365, 1998
16. Higgins RM, Gray DW, Morris PJ: Association of thrombosis after renal transplantation with elevation of the platelet count. Transplantation 59:1353-1355, 1995
17. Tschope D, Schwippert B, Schettler B, Kiesel U, Rothe H, Roesen P, Gries FA: Increased GPIIB/IIIA expression and altered DNA-ploidy pattern in megakaryocytes of diabetic BB-rats. Eur J Clin Invest 22:591-598, 1992
18. Mazzanti L, Rabini RA, Fumelli P, Martarelli D, Staffolani R, Salvolini E, Curatola G: Altered platelet membrane dynamic properties in type 1 diabetes. Diabetes 46:2069-2074, 1997
19. Winkler J, Fuchs J, Morduchowicz G, Boner G, Sulkiss J, Weinberger I: Circulating aggregated platelets, number of platelets per aggregate and platelet size in chronic dialysis patients. Nephron 77:44-47, 1997
20. Bath PM, Butterworth RJ: Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 7:157-161, 1996
21. Tschoepe D, Roesen P, Esser J, Schwippert B, Nieuwenhuis HK, Kehrel B, Gries FA: Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost 17:433-438, 1991
22. Cagliero E, Porta M, Cousins S, Kohner EM: Increased platelet volume in diabetic retinopathy. Hemostasis 12:293-299, 1982
23. Tschoepe D, Driesch E, Schwippert B, Lampeter EF, DENIS Study Group: Activated platelets in subjects at increased risk of IDDM. Diabetologia 40:573-577, 1997
24. Ishihara H, Connolly AJ, Zeng D, Kahn ML, Zheng YW, Timmons C, Tram T, Coughlin SR: Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386:502-506, 1997
25. Ishihara H, Zeng D, Connolly AJ, Tam C, Coughlin SR: Antibodies to protease-activated receptor 3 inhibit activation of mouse platelets by thrombin. Blood 91:4152-4157, 1998
26. Vicari AM, Monzani ML, Pellegatta F, Ronchi P, Galli L, Folli F: Platelet calcium homeostasis is abnormal in patients with severe arteriosclerosis. Arterioscler Thromb 14:1420-1424, 1994
27. Eggers PW: Effects of transplantation on the Medicare end-stage renal disease program. N Engl J Med 318:223-229, 1988
28. Secchi A, Caldara R, La Rocca E, Fiorina P, Di Carlo V: Cardiovascular disease and neoplasm after pancreas transplantation. Lancet 352:9121, 1998
29. Tyden G, Bolinder J, Solders G, Brattstrom C, Tibell A, Groth CG: Improved survival in patients with insulin-dependent diabetes mellitus and end-stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation. Transplantation 5:645-648, 1999
30. Sung RS, Althoen M, Howell TA, Merion RM: Peripheral vascular occlusive disease in renal transplant recipients: risk factors and impact on kidney allograft survival. Transplantation 70:1049-1054, 2000
31. La Rocca E, Fiorina P, Di Carlo V, Astorri E, Rossetti C, Lucignani G, Fazio F, Giudici D, Cristallo M, Bianchi G, Pozza G, Secchi A: Cardiovascular outcomes after kidney-pancreas and kidney-alone transplantation. Kidney Int 60:1964-1971, 2001
32. Fiorina P, La Rocca E, Venturini M, Minicucci F, Fermo I, Paroni R, D'Angelo A, Sblendido M, Di Carlo V, Cristallo M, Del Maschio A, Pozza G, Secchi A: Effects of kidney-pancreas transplantation on atherosclerotic risk factors and endothelial function in patients with uremia and type 1 diabetes. Diabetes 50:496-501, 2001
33. Fiorina P, Folli F, Bertuzzi F, Maffi P, Finzi G, Venturini M, Socci C, Davalli A, Orsenigo E, Monti L, Falqui L, Uccella S, La Rosa S, Usellini L, Properzi G, Di Carlo V, Del Maschio A, Capella C, Secchi A: Long-term beneficial effect of islet transplantation on diabetic macro-/microangiopathy in type 1 diabetic kidney-transplanted patients. Diabetes Care 26:1129-1136, 2003
34. Fiorina P, Folli F, Maffi P, Placidi C, Venturini M, Finzi G, Bertuzzi F, Davalli A, D'Angelo A, Socci C, Gremizzi C, Orsenigo E, La Rosa S, Ponzoni M, Cardillo M, Scalamogna M, Del Maschio A, Capella C, Di Carlo V, Secchi A: Islet transplantation improves vascular diabetic complications in patients with diabetes who underwent kidney transplantation: a comparison between kidney-pancreas and kidney-alone transplantation. Transplantation 75:1296-1301, 2003
35. Wyant TL, Smith PC, Brown B, Kantor AB: Whole blood microvolume laser scanning cytometry for monitoring resting and activated platelets. Platelets 12:309-318, 2001
36. Zucker-Franklin D, Kaushansky K: Effect of thrombopoietin on the development of megakaryocytes and platelets: an ultrastructural analysis. Blood 88:1632-1638, 1996
37. D'Angelo A, Della Valle P, Crippa L, Fattorini A, Pattarini E, Vigano D'Angelo S: Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment. Haematologica 87:1074-1080, 2002
38. Vigano D'Angelo S, Comp PC, Esmon CT, D'Angelo A: Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states. J Clin Invest 77:416-425, 1986
39. Viganò D'Angelo S, Tombesi S, Marcovina S, Albertini A, Delia Valle P, D'Angelo A: Monoclonal antibody-based enzyme-linked immunosorbent assays (ELISA) for measurement of vitamin K-dependent protein S: the effect of antibody immunoreactivity on plasma protein S antigen determinations. Thromb Haemost 67:631-638, 1992
40. Volpato S, Pahor M, Ferrucci L, Simonsick EM, Guralnik JM, Kritchevsky SB, Fellin R, Harris TB: Relationship of alcohol intake with inflammatory markers and plasminogen activator inhibitor-1 in well-functioning older adults: the Health, Aging, and Body Composition study. Circulation 109:607-612, 2004
41. Ma LJ, Mao SL, Taylor KL, Kanjanabuch T, Guan Y, Zhang Y, Brown NJ, Swift LL, McGuinness OP, Wasserman DH, Vaughan DE, Fogo AB: Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes 53:336-346, 2004
42. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LYC, Held PJ, Port FK: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341:1725-1730, 1999
43. Smets YF, Westendorp RG, van der Pijl JW, de Charro FT, Ringers J, de Fijter JW, Lemkes HH: Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure. Lancet 353:1915-1919, 1999
44. Moal V, Brunet P, Dou L, Morange S, Sampol J, Berland Y: Impaired expression of glycoproteins on resting and stimulated platelets in uraemic patients. Nephrol Dial Transplant 18:1834-1841, 2003
45. Sreedhara R, Itagaki I, Hakim RM: Uremic patients have decreased shear-induced platelet aggregation mediated by decreased availability of glycoprotein IIb-IIIa receptors. Am J Kidney Dis 27:355-364, 1996
46. Fellstrom B, Siegbahn A, Liljenberg G, Haglund O, Wallin R, Tufveson G, Bagge L: Primary haemostasis, plasmatic coagulation and fibrinolysis in renal transplantation. Thromb Res 59:97-104, 1990
47. Mezzano D, Tagle R, Panes O, Perez M, Downey P, Munoz B, Aranda E, Barja P, Thambo S, Gonzalez F, Mezzano S, Pereira J: Hemostatic disorder of uremia: the platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis. Thromb Haemost 76:312-321, 1996
48. Smith FB, Rumley A, Lee AJ, Leng GC, Fowkes FG, Lowe GD: Haemostatic factors and prediction of ischaemic heart disease and stroke in claudicants. Br J Haematol. 100:758-763, 1998
49. Rabini RA, Staffolani R, Fumelli P, Mutus B, Curatola G, Mazzanti L: Decreased nitric oxide synthase activity in platelets from IDDM and NIDDM patients. Diabetologia 41:101-104, 1998
50. Martina V, Bruno GA, Trucco F, Zumpano E, Tagliabue M, Di Bisceglie C, Pescarmona G: Platelet cNOS activity is reduced in patients with IDDM and NIDDM. Thromb Haemost 79:520-522, 1998
51. Loscalzo J: Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res 88:756-762, 2001
52. Pigazzi A, Heydrick S, Folli F, Benoit S, Michelson A, Loscalzo J: Nitric oxide inhibits thrombin receptor-activating peptide-induced phosphoinositide 3-kinase activity in human platelets. J Biol Chem 274:14368-14375, 1999
53. Ceriello A, Giacomello R, Stel G, Motz E, Taboga C, Tonutti L, Pirisi M, Falleti E, Bartoli E: Hyperglycemia-induced thrombin formation in diabetes: the possible role of oxidative stress. Diabetes 44:924-928, 1995
54. Kario K, Matsuo T, Yamada T, Nakao K, Shimano C, Matsuo M: Factor VII hyperactivity in chronic dialysis patients. Thromb Res 67:105-113, 1992